The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories View More Recent Stories
-
Apollo Global Q1 earnings fall 8%, missing estimates
-
KKR posts 26% drop in Q1 earnings, beating expectations
-
Form 13F-HR Carlyle Group Inc. For: Mar 31
-
Exclusive-Bain Capital nearing final close of Asia fund worth $6 billion - sources
-
Form 10-K/A Carlyle Group Inc. For: Dec 31
-
Form 10-Q Carlyle Group Inc. For: Mar 31
-
The Carlyle Group (CG) Misses Q1 EPS by 5c
-
Carlyle shares fall after Q1 earnings miss estimates
-
Form 8-K Carlyle Group Inc. For: May 04
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: HANCE JAMES H JR
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: Rice Derica W
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: FITT LAWTON W
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: ORDAN MARK S
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: ROBERTSON THOMAS S
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: WELTERS ANTHONY
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: SHAW WILLIAM JOSEPH
-
Form 4 Carlyle Group Inc. For: May 01 Filed by: FILLER LINDA
-
iC Consult Americas Appoints Jonathan Edwards as CEO
-
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
-
Global elite heads to Milken event to talk banks, rates and recession
-
Sedgwick launches Sidekick+, first-of-its-kind application using OpenAI GPT-4 tool
-
Greycroft Closes On More Than $1 Billion To Back the Next Generation of Category-Defining Companies
-
Form DEFA14A Carlyle Group Inc.
-
Form 8-K Carlyle Group Inc. For: Apr 25
-
Carlyle Appoints Sharda Cherwoo as an Independent Director
-
Sedgwick named to Forbes' Best Employers for Diversity 2023
-
Carlyle eyes fresh backers for McDonald's China arm -Bloomberg News
-
Dominion Voting owner says Fox held accountable even without apology
-
Capital Power Announces Appointment of Avik Dey as President and Chief Executive Officer, Brian Vaasjo to Retire
-
Fox's $787.5 million settlement is big win for buyout firm Staple Street
-
Sedgwick acquires Appraisal Service of Mississippi, Inc.
-
Hilb Group Grows New England Property and Casualty Presence
-
Form SC 13D/A Vera Therapeutics, Inc. Filed by: Carlyle Group Inc.
-
Form SC 13D/A EXICURE, INC. Filed by: Carlyle Group Inc.
-
Sedgwick named to Newsweek's America's Greatest Workplaces for LGBTQ+ 2023
-
Hilb Group Continues to Build on Marine, Property and Casualty Presence
-
Airlines, repair shops in N. America eye used, generic parts to keep aircraft flying
-
Form DEF 14A Carlyle Group Inc.
-
Form ARS Carlyle Group Inc. For: Dec 31
-
Form DEFA14A Carlyle Group Inc.
-
Veritas, Carlyle end talks on Cotiviti stake sale - source
-
NEP’s Global Production Ecosystem Expansion Goes Live in the U.S.
-
Sedgwick brand protection executive Chris Harvey has been appointed to the International Consumer Product Health and Safety Organization executive committee
-
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
-
The Carlyle Group (CG) call put ratio 8.9 calls to 1 put
-
The Carlyle Group (CG) 30-day option implied volatility at 39
-
Cognizant Names Bram Schot to Board of Directors
-
Net Health's PointRight® Analytics Solution First to Receive Quality Measure Endorsements by National Quality Forum
-
Apollo assures investors deposit flight won't spill over to Athene
-
PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN

